background image

Clinical Trials In Anaheim

Discover hundreds of clinical trials in Anaheim.
Search clinical trials in Anaheim by condition or phase.

e.g. Respiratory Diseases
AnaheimHealthy volunteers: No

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Anaheim, Garden Grove, Orange, Long Beachshow 42 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Recruiting
PHASE1
PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Los Angeles

Code:

NCT06324357

Conditions

Metastatic Breast Cancer

Metastatic Gastric Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma

Esophageal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zongertinib

Trastuzumab deruxtecan

Trastuzumab emtansine

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

Recruiting
PHASE1

Sponsor:

University of Southern California

Location:

Los Angeles

Code:

NCT06338657

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

PEOX-based Polymer Encapsulated Paclitaxel FID-007

Tumor Resection

Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Recruiting
PHASE1

Sponsor:

SciTech Development, LLC

Location:

Los Angeles, Aurora, Houston, Ann Arborshow 3 more

Code:

NCT04234048

Conditions

T-cell Lymphoma

Cutaneous/Peripheral T-Cell Lymphoma

Peripheral T-cell Lymphoma

Peripheral T-Cell Lymphoma, Not Classified

Primary Cutaneous T-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fenretinide

A Study Evaluating APG777 in Atopic Dermatitis

Recruiting
PHASE2

Sponsor:

Apogee Therapeutics, Inc.

Location:

Fountain Valley, San Diego, Portland, Mill Creekshow 27 more

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Newport Beach, Pasadena, Santa Monica, Northridgeshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

A Biobehavioral Intervention for Young Men With Testicular Cancer

Recruiting
PHASE2

Sponsor:

UCLA

Location:

Irvine, New York

Code:

NCT04150848

Conditions

Testis Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 39

Healthy Volunteers: Not accepted

Interventions

Goal-Focused Emotion Regulation Therapy (GET)

Individual Supportive Psychotherapy (ISP)

Impact of Intraoperative ICG on Functional Outc in RARP

Recruiting
EARLY_PHASE1

Sponsor:

UCLA

Location:

Orange

Code:

NCT06446648

Conditions

Prostate Adenocarcinoma

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICG

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Orange, Los Angeles, Loma Linda, San Diegoshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Recruiting
PHASE2

Sponsor:

Replimune Inc.

Location:

Orange, Los Angeles, La Jolla, Saint Georgeshow 20 more

Code:

NCT03767348

Conditions

Cancer

Melanoma (Skin)

Mismatch Repair Deficiency

Microsatellite Instability

Non-melanoma Skin Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RP1

nivolumab